NCT07488676 2026-04-15A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsAstellas Pharma IncPhase 1/2 Recruiting150 enrolled
NCT02077881 2026-04-03Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerLumos PharmaPhase 1/2 Completed157 enrolled 18 charts
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 5 FDA